Sertraline

Sertraline is indicated for the treatment of:

Major depressive episodes. Prevention of recurrence of major depressive episodes. Panic disorder, with or without agoraphobia. Obsessive compulsive disorder (OCD) in adults and paediatric patients aged 6-17 years. Social anxiety disorder.

Post traumatic stress disorder (PTSD)

PRO-SERTRALINE (sertraline hydrochloride capsules) is indicated for:

Adults • Depression PRO-SERTRALINE is indicated for the symptomatic relief of depressive illness. However, the antidepressant action of sertraline in hospitalized depressed patients has not been adequately studied. A placebo-controlled European study carried out over 44 weeks, in patients who were responders to sertraline has indicated that sertraline may be useful in continuation treatment, suppressing reemergence of depressive symptoms.

However, because of methodological limitations, these findings on continuation treatment have to be considered tentative at this time. • Panic Disorder PRO-SERTRALINE is indicated for the symptomatic relief of panic disorder, with or without agoraphobia.

The efficacy of sertraline was established in 10-week and 12-week controlled trials of patients with panic disorder as defined according to DSM-III-R criteria. , for more than 12 weeks) has not been systematically evaluated in placebo-controlled trials.

1 INDICATIONS AND USAGE Sertraline hydrochloride tablets are indicated for the treatment of the following [ See Clinical Studies (14) ]: • Major depressive disorder (MDD) • Obsessive-compulsive disorder (OCD) • Panic disorder (PD) • Posttraumatic stress disorder (PTSD) • Social anxiety disorder (SAD) • Premenstrual dysphoric disorder (PMDD) Sertraline hydrochloride tablets are a selective serotonin reuptake inhibitor (SSRI) indicated for the treatment of ( 1 ): Major depressive disorder (MDD) Obsessive-compulsive disorder (OCD) Panic disorder (PD) Posttraumatic stress disorder (PTSD) Social anxiety disorder (SAD) Premenstrual dysphoric disorder (PMDD)